We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Could Boost Clinical Adoption of Chest DDR

By MedImaging International staff writers
Posted on 01 Apr 2024
Print article
Image: AI could help chest DDR achieve clinical adoption (Photo courtesy of 123RF)
Image: AI could help chest DDR achieve clinical adoption (Photo courtesy of 123RF)

For diagnosing lung conditions, healthcare professionals typically rely on chest X-rays and pulmonary function tests (PFTs), which provide a snapshot of lung health. However, these traditional methods only offer a limited static assessment. Recent advancements have highlighted chest dynamic digital radiography (DDR) as a valuable tool for observing the lungs and diaphragm in motion, offering insights into respiratory function that static images are not capable of. Despite its potential benefits, the widespread adoption of DDR in clinical practice has been hampered by the manual, time-intensive analysis required and its unestablished correlation with standard PFT results. Now, the clinical use of chest DDR in patients with lung disorders could receive a significant boost with the development of artificial intelligence (AI) to perform the time-consuming analysis involved in the technology.

Researchers at Mount Sinai Hospital (New York, NY, USA) have developed a sophisticated AI "pipeline" utilizing convolutional neural networks (CNNs) to analyze sequences of DDR images of the lungs from patients. This approach aims to replicate the results of standard pulmonary function tests, effectively bridging the gap between DDR technology and conventional respiratory assessment methods. They created two specific CNNs for evaluating key aspects of lung movement in DDR sequences, using data from 55 patients representing a spectrum of lung health - from normal to those with obstructive and restrictive lung conditions. These CNNs were tasked with measuring lung areas in the images, essentially creating DDR-based pulmonary function tests (dPFTs). The researchers then undertook a comparative analysis of dPFTs against standard PFT measurements.

Their findings revealed statistically significant and strong correlations between the dPFT measurements and traditional PFT values, including total lung capacity, forced expiratory volume in one second, vital capacity, and functional residual capacity. These correlations indicate that dPFTs could potentially serve as alternatives to conventional PFTs, especially in scenarios where traditional tests are not feasible or available. DDR presents several advantages over conventional methods, including reduced radiation exposure compared to standard chest X-rays and the ability to provide valuable diagnostic information in situations where PFTs are inaccessible, such as for patients with neuromuscular disorders or during acute exacerbations of chronic obstructive pulmonary disease, concluded the researchers.

“Our study demonstrates robust dPFTs and PFTs correlations using an automated DDR analysis pipeline. This pipeline has potential to discern normal from abnormal physiology, suggesting dPFTs are valuable in assessing lung dynamics,” concluded the researchers.

Related Links:
Mount Sinai Hospital

Ultrasound Imaging System
P12 Elite
Ultrasonic Pocket Doppler
SD1
Radiation Therapy Treatment Software Application
Elekta ONE
Wall Fixtures
MRI SERIES

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.